SCHEMBL20056731

SCHEMBL20056731

CNCC(=O)NC(C)C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TAS1R3 Q7RTX0 3/20 0.42
TAS1R1 Q7RTX1 3/20 0.42
TAS1R2 Q8TE23 3/20 0.42
SIGMAR1 Q99720 1/20 0.41
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HPGD P15428 2/20 0.35
ALDH1A1 P00352 1/20 0.34
ACACB O00763 1/20 0.33
MMP1 P03956 2/20 0.32
MMP2 P08253 2/20 0.32
MMP3 P08254 2/20 0.32
MMP9 P14780 2/20 0.32
MMP8 P22894 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23565702 0.79 CYP3A4 (0.41) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL24153230 0.79 MEN1 (0.36) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL31483043 0.77 CYP2C9 (0.46) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL18678083 0.77 ALDH1A1 (0.40) CYP2C9TAS1R3TAS1R1TAS1R2MEN1
SCHEMBL16298847 0.77 CYP2C9 (0.46) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL8243268 0.77
SCHEMBL1018455 0.76 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL8433156 0.76 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL13826479 0.76 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL1018454 0.76 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3892305-A1 HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY Sutro Biopharma, Inc. (US) 2021-10-13 EP disclosed
EP-3250237-B1 HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY SUTRO BIOPHARMA INC (US) 2021-05-26 EP disclosed
EP-1883627-B1 BIR DOMAIN BINDING COMPOUNDS PHARMASCIENCE INC (CA) 2018-04-18 EP disclosed